IL6 and depressive symptom measurement: These results suggested that the Acp5 upregulation mediated by the IL-6/STAT3 pathway, via modulating the activity of PrL pyramidal neurons, contributed to the formation of neuropathic pain/depression comorbid induced by SNI in rats.